Delivery Order SPE2DB20D1109-SPE2DB25FN84H

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,344.91 firm fixed-price delivery order is for the supply of 4,567,198 units of Topiramate 25 mg tablets. The contract, which has an ultimate completion date of February 10, 2025, does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order worth $1,015.44 for the provision of Topiramate ER 25 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through March 2023. The contract is a firm-fixed-price agreement and was not set aside for any specific business type. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $16,312.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of Topiramate ER 25 mg capsules, a medication used to treat certain types of seizures and migraines. The contract has a period of performance through March 5, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,579.40 firm fixed-price delivery order is for the supply of 4,568,146,788 units of the medication Topiramate 25 mg Tablet, with a completion date of May 6, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,260.30, is for the delivery of 4,565,259,196 units of Topiramate 25 mg Tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $15,398.48, is for the delivery of Topiramate ER 100 mg capsules and has an ultimate completion date of October 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,027.22 Firm Fixed Price Delivery Order is for the supply of Topiramate 25 mg tablets, a medication used to treat various medical conditions. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $22,218.31 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4561313560 topiramate ER 100mg capsules. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for the company to provide a...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEKZ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,951.11 firm fixed-price delivery order is for the supply of 4,568,072,912 units of the medication Topiramate ER 25 mg capsules. The contract has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,621.64 firm fixed-price delivery order is for the supply of 100 mg Topiramate ER capsules, a medication used to treat various medical conditions. The award has an ultimate completion date of October 13, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN84H
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $2,502.81, is for the delivery of Topiramate ER 25 mg capsules over a period ending on April 8, 2025. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 7/7/25, 1:02 PM